Home / Recalls / Alembic Pharmaceuticals Limited / D-0326-2021

D-0326-2021 Class I Terminated

Recalled by Alembic Pharmaceuticals Limited — Tajpura, N/A

Recall Details

Product Type
Drugs
Report Date
April 14, 2021
Initiation Date
March 17, 2021
Termination Date
December 5, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12288 bottles

Product Description

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30

Reason for Recall

Labeling: Label-mixup

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 1905005661, Exp March 2022

Other recalls by Alembic Pharmaceuticals Limited

  • D-0248-2026 Class III — Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manu (December 16, 2025)
  • D-0156-2026 Class III — Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, (October 10, 2025)
  • D-0566-2025 Class II — Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured (July 25, 2025)
  • D-0459-2025 Class II — Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic (May 9, 2025)
  • D-0447-2025 Class II — Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactur (May 7, 2025)
  • D-1341-2020 Class II — Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by (June 10, 2020)